Literature DB >> 34748378

Influenza.

Timothy M Uyeki1.   

Abstract

Seasonal influenza epidemics of variable severity pose challenges to public health. Annual vaccination is the primary way to prevent influenza, and a wide range of vaccines are available, including inactivated or live attenuated standard-dose, recombinant vaccines, as well as adjuvanted or high-dose vaccines for persons aged 65 years or older. Persons at increased risk for influenza complications include young children, persons with underlying medical conditions, and older adults. Prompt diagnosis of influenza can facilitate early initiation of antiviral treatment that provides the greatest clinical benefit. This article summarizes recommendations for providers on influenza vaccination, diagnostic testing, and antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34748378     DOI: 10.7326/AITC202111160

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  Emergence of circulating influenza A H3N2 viruses with genetic drift in the matrix gene: be alert of false-negative test results.

Authors:  Rikke Lind Jørgensen; Christian Johann Lerche; Martin Schou Pedersen; Nikolai Soren Kirkby; Amanda Bolt Botnen; Ramona Trebbien; Stephen Nilsson-Møller; Mette Pinholt; Alex Christian Yde Nielsen; Henrik Westh; Jan Gorm Lisby; Uffe Vest Schneider
Journal:  APMIS       Date:  2022-08-10       Impact factor: 3.428

Review 2.  Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication.

Authors:  Ralph A Tripp; David E Martin
Journal:  Viruses       Date:  2022-03-15       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.